Publications by authors named "Tehseen Salimi"

Claim this Profile
O
Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence.
Amer M Zeidan, Ruizhi Zhao, Robert S Epstein, Tehseen Salimi

Expert Rev Anticancer Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.
Amer M Zeidan, Kate Perepezko, Tehseen Salimi, Terri Washington, Robert S Epstein

Ther Adv Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futibatinib for -Rearranged Intrahepatic Cholangiocarcinoma.
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Tehseen Salimi

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.
Amer M Zeidan, Namita Joshi, Hrishikesh Kale, Wei-Jhih Wang, Shelby Corman, Tehseen Salimi

Clin Lymphoma Myeloma Leuk· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.
Robert S Epstein, Roshanthi K Weerasinghe, Amy S Parrish, JoAnn Krenitsky, Rachel E Sanborn, Tehseen Salimi

J Med Econ· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?
Amer M Zeidan, Tehseen Salimi, Robert S Epstein

Future Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.
Robert S Epstein, Upal K Basu Roy, Matti Aapro, Tehseen Salimi, Donald Moran

Patient Prefer Adherence· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.
Robert S Epstein, Matti S Aapro, Upal K Basu Roy, Tehseen Salimi, JoAnn Krenitsky

Adv Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice Patterns and Treatment Challenges in Acute Postoperative Pain Management: A Survey of Practicing Physicians.
Tong J Gan, Robert S Epstein, Megan L Leone-Perkins, Tehseen Salimi, Sheikh Usman Iqbal

Pain Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014.
Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson, Betina Blak, Yanli Zhao, Tehseen Salimi

Hum Vaccin Immunother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European and Russian physician awareness of best management approaches for infections due to antibiotic-resistant Gram-negative bacteria.
Paurus Irani, Tehseen Salimi, Robert Epstein, Megan Leone-Perkins, Ronald Aubert

Curr Med Res Opin· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When People with Opioid-Induced Constipation Speak: A Patient Survey.
Robert S Epstein, J Russell Teagarden, Ali Cimen, Mark Sostek, Tehseen Salimi

Adv Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value".
Sheikh Usman Iqbal, Tehseen Salimi, John Dunlop, L Clark Paramore

Ther Innov Regul Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for change in symptoms associated with opioid-induced constipation.
Robert S Epstein, Ali Cimen, Hannah Benenson, Ronald E Aubert, Mona Khalid, Tehseen Salimi

Adv Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A framework for pharmaceutical value-based innovations.
Tehseen Salimi, Jean-Pierre Lehner, Robert S Epstein, Sean R Tunis

J Comp Eff Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating scientific and real-world evidence within and beyond the drug development process.
Robert S Epstein, Jaan Sidorov, Jean-Pierre Lehner, Tehseen Salimi

J Comp Eff Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating new approaches for clinical development: translational research and relative effectiveness.
Jean-Pierre Lehner, Robert S Epstein, Tehseen Salimi

J Comp Eff Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis